- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: VX-740 | VX740
Compound class: Synthetic organic
Comment: Pralnacasan (VX-740) is a selective, non-peptide caspase 1 inhibitor that was developed by Vertex for anti-inflammatory potential. Inhibition of caspase 1 is a small molecule strategy developed as an alternative to the use of anti-IL-1β neutralising antibodies, such as canakinumab, or the dimeric fusion protein rilonacept that acts as a IL-1 trap.
Pralnacasan is a prodrug whose active metabolite is VRT-018858 .
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|International Nonproprietary Names
|VX-740 | VX740
|CAS Registry No.
|GtoPdb PubChem SID
|Search Google for chemical match using the InChIKey
|Search Google for chemicals with the same backbone
|Search PubMed clinical trials
|Search PubMed titles
|Search PubMed titles/abstracts
|UniChem Compound Search for chemical match using the InChIKey
|UniChem Connectivity Search for chemical match using the InChIKey